" what are the inordinate salaries being paid FOR? "
In my view management should be focusing on two things:
1. articulating the Axiron market opportunity so investors can accurately price this company. Management has failed miserably at telling the story on this product and consequently the shorts have had a field day. Management tells us that MacBank is wrong in its research - but it has failed to convince investors why this is the case. Likewise with the FDA product warning - the BellPotter research has done a far superior job of informing about the issues... we have had NO information from management on this. Here's an idea - STOP USING THAT REPETITIVE AND GENERIC INVESTOR PRESENTATION (which says nothing) and actually put together a compelling argument as to why we should own ACR!!!
2. provide the market with a plan for new products. An update focused on each opportunity in the pipeline (excluding Axiron), key milestones along with markets and the size of each opportunity. the what, why, when and how is missing from the pipeline and consequently investors are ascribing zero value to this.
So in my opinion is all about communication followed by action here. Staying quiet is not a option. Management must show it has a plan and sell the dream to the market. without that - this stock is adrift on the market and will continued to be manipulated by the big boys and algo trader bots out there.
Add to My Watchlist
What is My Watchlist?
